Moreover, in a retrospective, chart review-based study, 8 of 11 patients with a radiologic diagnosis of MASLD treated with PCSK9i for any reason reached complete radiological resolution of MASLD with a statistically significant reduction in serum ALT levels [241]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.